Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

[Care of frail elderly patients--evidence-based approach exists].

Ekdahl AW, Ivanoff SD, Ehrenberg A, Oredsson S, Sjöstrand F, Stavenow L, Wisten A.

Lakartidningen. 2014 Feb 12-18;111(7):256-7. Swedish. No abstract available.

PMID:
24669484
2.

Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study.

Torisson G, Minthon L, Stavenow L, Londos E.

Clin Interv Aging. 2013;8:1295-304. doi: 10.2147/CIA.S49133. Epub 2013 Sep 26.

3.

Cognitive impairment is undetected in medical inpatients: a study of mortality and recognition amongst healthcare professionals.

Torisson G, Minthon L, Stavenow L, Londos E.

BMC Geriatr. 2012 Aug 24;12:47. doi: 10.1186/1471-2318-12-47.

4.

[Better care for elderly with co-existing diseases: how do we manage recruitment of those who are to do the job?].

Stavenow L.

Lakartidningen. 2009 Oct 21-27;106(43):2780. Swedish. No abstract available.

PMID:
19960908
5.

Consequences of orthostatic blood pressure variability in middle-aged men (The Malmö Preventive Project).

Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O.

J Hypertens. 2010 Mar;28(3):551-9. doi: 10.1097/HJH.0b013e3283350e8c.

PMID:
19952779
6.

Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).

Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O.

Eur Heart J. 2010 Jan;31(1):85-91. doi: 10.1093/eurheartj/ehp329. Epub 2009 Aug 20.

7.

Incidence of myocardial infarction and death in relation to walking-induced calf pain and plasma levels of inflammation-sensitive proteins.

Lind P, Hedblad B, Stavenow L, Engström G, Janzon L, Ogren M, Lindgärde F.

Angiology. 2005 Sep-Oct;56(5):507-16.

PMID:
16193189
8.

Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study.

Engström G, Hedblad B, Stavenow L, Tydén P, Lind P, Janzon L, Lindgärde F.

Circulation. 2004 Jul 6;110(1):27-31. Epub 2004 Jun 21.

9.

Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study.

Engström G, Hedblad B, Stavenow L, Jonsson S, Lind P, Janzon L, Lindgärde F.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1498-502. Epub 2004 Jun 3.

10.

Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins.

Lind P, Engström G, Stavenow L, Janzon L, Lindgärde F, Hedblad B.

Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):577-82. Epub 2004 Jan 15.

11.

Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk.

Engström G, Stavenow L, Hedblad B, Lind P, Tydén P, Janzon L, Lindgärde F.

Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2247-51.

12.

Risk of myocardial infarction in relation to plasma levels of homocysteine and inflammation-sensitive proteins: a long-term nested case-control study.

Lind P, Hedblad B, Hultberg B, Stavenow L, Janzon L, Lindgärde F.

Angiology. 2003 Jul-Aug;54(4):401-10.

PMID:
12934759
13.

Inflammation-sensitive plasma proteins are associated with future weight gain.

Engström G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgärde F.

Diabetes. 2003 Aug;52(8):2097-101.

14.

Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study.

Engström G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, Lindgärde F.

Diabetes. 2003 Feb;52(2):442-7.

15.

Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins.

Engström G, Janzon L, Berglund G, Lind P, Stavenow L, Hedblad B, Lindgärde F.

Arterioscler Thromb Vasc Biol. 2002 Dec 1;22(12):2054-8.

16.

Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke.

Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F.

Stroke. 2002 Dec;33(12):2744-9.

17.

Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins.

Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgärde F.

Circulation. 2002 Nov 12;106(20):2555-60.

18.

Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men.

Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F.

Circulation. 2002 Jun 4;105(22):2632-7.

19.

Endocardial expression and functional characterization of endothelin-1.

Saetrum Opgaard O, Adner M, Peters TH, Xu CB, Stavenow L, Gulbenkian S, Erlinge D, Edvinsson L, Sharma HS.

Mol Cell Biochem. 2001 Aug;224(1-2):151-8.

PMID:
11693192
20.

Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study.

Lind P, Hedblad B, Stavenow L, Janzon L, Eriksson KF, Lindgärde F.

Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):452-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk